Literature DB >> 14706197

[Effects of acidi fibroblast growth factor on hepatic and renal functions after intestinal ischemia/reperfusion injury].

Li-xin Weng1, Xiao-bing Fu, Xiu-xia Li, Tong-zhu Sun, Shu-yun Zheng, Wei Chen.   

Abstract

OBJECTIVE: To investigate the change in hepatic and renal functions parameters after intestinal ischemia-reperfusion (I/R) injury, and to explore the effects of acidic fibroblast growth factor (aFGF) on hepatic and renal functions after intestinal I/R injury in rats.
METHODS: Seventy-eight Wistar rats were divided into four groups, which are sham-operated (C) group, ischemia (45 minutes) plus reperfusion (R), reconstructive human aFGF treatment (rhF), and wild type aFGF treatment (wtF) groups. The animals were sacrificed at 2, 6, 12 and 24 hours, respectively. Hepatic and renal functions were analyzed.
RESULTS: In comparison with those in group C, the hepatic and renal functions were damaged in group R, rhF and wtF decreased. Treatment with rhF and wtF markedly abated the hepatic and renal dysfunction. The desquamation of intestine villi and infiltration of inflammation cells in the submucosa were observed in all groups.
CONCLUSION: Hepatic and renal functions are damaged after intestinal I/R injury. Treatment with rhF and wtF could protect against multiple organ dysfunction associated with intestinal ischemia-reperfusiun injury.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14706197

Source DB:  PubMed          Journal:  Zhongguo Wei Zhong Bing Ji Jiu Yi Xue        ISSN: 1003-0603


  4 in total

1.  Exogenous acid fibroblast growth factor inhibits ischemia-reperfusion-induced damage in intestinal epithelium via regulating P53 and P21WAF-1 expression.

Authors:  Wei Chen; Xiao-Bing Fu; Shi-Li Ge; Wen-Juan Li; Tong-Zhu Sun; Zhi-Yong Sheng
Journal:  World J Gastroenterol       Date:  2005-11-28       Impact factor: 5.742

2.  Acid fibroblast growth factor reduces rat intestinal mucosal damage caused by ischemia-reperfusion insult.

Authors:  Wei Chen; Xiao-Bing Fu; Shi-Li Ge; Tong-Zhu Sun; Wen-Juan Li; Zhi-Yong Sheng
Journal:  World J Gastroenterol       Date:  2005-11-07       Impact factor: 5.742

3.  Intravenous acid fibroblast growth factor protects intestinal mucosal cells against ischemia-reperfusion injury via regulating Bcl-2/Bax expression.

Authors:  Wei Chen; Xiao-Bing Fu; Shi-Li Ge; Tong-Zhu Sun; Gang Zhou; Bing Han; Yi-Ri Du; Hai-Hong Li; Zhi-Yong Sheng
Journal:  World J Gastroenterol       Date:  2005-06-14       Impact factor: 5.742

Review 4.  Fibroblast Growth Factors in the Management of Acute Kidney Injury Following Ischemia-Reperfusion.

Authors:  Lian-Cheng Deng; Tahereh Alinejad; Saverio Bellusci; Jin-San Zhang
Journal:  Front Pharmacol       Date:  2020-04-08       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.